Richard S. Kollender
Chief Operating Officer
Prior to assuming the role of chief operating officer at Strongbridge, Richard served as a member of the Company’s board of directors from March 2015 to September 2019. He brings 25 years of operational, business development and finance experience in the healthcare industry. Since 2003, he has served as a principal and partner of Quaker Partners, a healthcare venture fund. In addition, from August 2016 through September 2018, he served as chief business officer and chief financial officer of Rapid Micro Biosystems, a Quaker Partners’ portfolio company. Earlier in his career, Richard held positions in sales, marketing and worldwide business development at GlaxoSmithKline and served as investment manager at its corporate venture capital arm, S.R. One. Richard currently serves as chairman of the board of directors for Restorative Therapies. He also serves on the board of directors for Rapid Micro Biosystems and as an adjunct faculty member at Lehigh University. He previously served on the board of directors of Insmed, NuPathe, Inc., Precision Therapeutics, Inc., and Celator Pharmaceuticals, Inc.
Richard holds an MBA and a certificate degree in the graduate program in health administration and policy from the University of Chicago and a BA in accounting from Franklin and Marshall College.